Cargando…
Constitutive Expression of Interleukin (IL)-4 In Vivo Causes Autoimmune-type Disorders in Mice
The transgenic (tg) expression of interleukin (IL)-4 under the control of a major histocompatibility complex (MHC) class I promoter leads to B cell hyperactivity in mice, characterized by increased B cell surface MHC class II and CD23 expression, elevated responsiveness of the B cells to polyclonal...
Autores principales: | Erb, Klaus J., Rüger, Beate, von Brevern, Maja, Ryffel, Bernhard, Schimpl, Annelise, Rivett, Karen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196114/ https://www.ncbi.nlm.nih.gov/pubmed/9016881 |
Ejemplares similares
-
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
por: Segal, Benjamin M., et al.
Publicado: (1998) -
The injustice of COVID-19: we need a moral constitution for our planet's health
por: Ruger, Jennifer Prah
Publicado: (2020) -
Interleukin-13 (IL-13)in autoimmune rheumatic diseases: relationship with autoantibody profile
por: Rinaldi, T, et al.
Publicado: (2001) -
Innate type 1 immune response, but not IL-17 cells control tuberculosis infection
por: Segueni, Noria, et al.
Publicado: (2021) -
A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis
por: Sutton, Caroline, et al.
Publicado: (2006)